| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Summit Therapeutics Inc. | Director | Stock Option (right to buy) | 7,180 | $62,896 | $8.76 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | 02 Jan 2026 | 2 | +$62,897 | 4 | Director | 06 Jan 2026, 18:55 |
| SMMT | Summit Therapeutics Inc. | 02 Jan 2025 | 2 | +$62,929 | 4 | Director | 06 Jan 2025, 18:57 |
| SMMT | Summit Therapeutics Inc. | 02 Jan 2024 | 2 | +$62,899 | 4 | Director | 04 Jan 2024, 16:27 |
| SMMT | Summit Therapeutics Inc. | 03 Jan 2023 | 2 | +$54,609 | 4 | Director | 05 Jan 2023, 15:21 |
| SMMT | Summit Therapeutics Inc. | 28 Sep 2022 | 0 | $0 | 3 | Director | 03 Oct 2022, 16:51 |
| SMMT | Summit Therapeutics Inc. | 28 Sep 2022 | 2 | $0 | 4 | Director | 03 Oct 2022, 16:50 |